Status:
COMPLETED
Effectiveness of the Supportive and Palliative Care Review Kit (SPARK) for Cancer Patients in the Acute Hospital
Lead Sponsor:
National Cancer Centre, Singapore
Collaborating Sponsors:
Singapore General Hospital
Duke-NUS Graduate Medical School
Conditions:
Health Services Research
Eligibility:
All Genders
21-110 years
Phase:
NA
Brief Summary
Introduction There is a rising need for palliative care services in Singapore due to a rapidly ageing population and an increasing incidence of cancer. Current existing resources are inadequate - nov...
Eligibility Criteria
Inclusion
- All patients admitted under the care of the medical oncology team in Singapore General Hospital will be included.
Exclusion
- Patients below 21 years old.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
7514 Patients enrolled
Trial Details
Trial ID
NCT03330509
Start Date
December 1 2017
End Date
December 30 2021
Last Update
April 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Centre Singapore
Singapore, Singapore, 169610